Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
Solving the Puzzle of Cell Culture Optimization
Assembling a Jigsaw Puzzle Is Not Nearly as Tricky as Building a Stable and Productive Bioprocess
Biotech Innovations: Overhyped?
While there’s no argument that biotechnology has dramatically improved global healthcare with the introduction of many novel biotherapeutics, there have been some huge hopes for a number of novel drug products and innovative technologies that for various reasons never came to fruition. GEN recently posted a list of 10 biotechnologies that have yet to live up to their hype, which begs the question: Is the tech or the big talk to blame?